Q3 FY2026 · ended Sep 30, 2026 · Revenue $51.43B, +1.4% YoY · Filed Oct 21, 2026
Elevance Health, Inc. (ELV) files with the SEC under industry code 6324, Hospital & Medical Service Plans. In Q3 of fiscal 2026, the quarter ended Sep 30, 2026, it reported revenue of $51.4 billion and net income of $1.4 billion. Free cash flow was $1.0 billion. As of Sep 30, 2026 it held $36.9 billion in cash and investments and $30.8 billion in total debt.
Revenue
$51.43B
+1.4% vs year-ago quarter
Net income
$1.36B
+14.8% vs year-ago quarter
Operating cash flow
$1.27B
+11.6% vs year-ago quarter
Free cash flow
$1.00B
+29.0% vs year-ago quarter
EPS
$6.27
+17.9% vs year-ago quarter
Dividend per share
$1.72
+0.6% vs year-ago quarter
Shares outstanding
216.06M
-2.8% vs year-ago quarter
Net cash
$6.15B
Q3 FY2026
Operating margin
2.7%
TTM
Company profile
- Industry
- Hospital & Medical Service Plans (SIC 6324)
- Listed as
- ELV (NYSE)
- Fiscal year ends
- December 31
- Incorporated in
- IN
- Headquarters
- Indianapolis, IN
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1156039
- Former names
- Anthem, Inc. (until Jun 24, 2022); WELLPOINT, INC (until Nov 12, 2014); WELLPOINT INC (until Dec 21, 2009); ANTHEM INC (until Nov 30, 2004)
Other Hospital & Medical Service Plans companies
- Unitedhealth Group Inc UNH
- Cigna Group CI
- Humana Inc HUM
- Centene Corp CNC
- Molina Healthcare, Inc. MOH
- Oscar Health, Inc. OSCR
- Clover Health Investments, Corp. /DE CLOV
- Alignment Healthcare, Inc. ALHC
Key figures
Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.
| Line | Q3 FY2026 Sep 30, 2026 |
Q2 FY2026 Jun 30, 2026 |
Q1 FY2026 Mar 31, 2026 |
Q4 FY2025 Dec 31, 2025 |
Q3 FY2025 Sep 30, 2025 |
|---|---|---|---|---|---|
| Revenue | $51.4B | $50.5B | $50.2B | $49.7B | $50.7B |
| Operating income | $1.3B | $1.8B | $2.1B | $309.0M | $1.3B |
| Net income | $1.4B | $1.5B | $1.8B | $547.0M | $1.2B |
| Diluted EPS | $6.27 | $6.71 | $8.00 | $2.47 | $5.32 |
| Operating cash flow | $1.3B | $1.9B | $4.3B | $84.0M | $1.1B |
| Free cash flow | $1.0B | $1.6B | $4.1B | -$209.0M | $775.0M |
| Total assets | $127.8B | $126.4B | $125.8B | $121.5B | $122.7B |
| Total liabilities | $83.0B | $81.4B | $81.8B | $77.5B | $78.7B |
| Stockholders' equity | $44.7B | $44.9B | $43.9B | $43.9B | $44.0B |
| Cash and investments | $36.9B | $37.2B | $36.7B | $36.5B | $36.1B |
| Total debt | $30.8B | $31.0B | $31.8B | $32.7B | $32.1B |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Oct 21, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Results of operations
|
Oct 21, 2026 | Oct 21, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 10, 2026 | Sep 10, 2026 |
| 10-Q | Quarterly report | Jul 15, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Jul 15, 2026 | Jul 15, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 10, 2026 | Jun 10, 2026 |
All 1000 Elevance Health, Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.